Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

By E. Brunt, D. Kleiner, L. Wilson, Patricia H. Belt, B. Neuschwander‐Tetri. Hepatology, 2011

1,153 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/a0dbd66a9ebce41e8d02aaf442437d91264bc223

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. L. Adams
2. Z. Younossi

In Epidemiology

1. L. Adams
2. D. Kleiner
3. Z. Younossi

Citations in the corpus

• Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients (2012, methodology): “, diagnosis of NASH), although clinical trials have often selected patients with NASH based on an NAS value 5.(23,27) Consistent with previous studies, our study shows that, in obese patients, NAS does not match closely with the diagnosis of NASH.”
• Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (2015, methodology): “The diagnosis of NASH as determined by the reporting histopathologist was recorded and categorized as non-NASH, borderline/suspicious NASH, or definitive NASH as proposed [12].”